Assaf A Barg Selected Research

marstacimab

1/2022

Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Assaf A Barg Research Topics

Disease

9	Hemophilia A (Haemophilia) 01/2022 - 03/2017
7	Hemorrhage 01/2022 - 03/2017
2	von Willebrand Diseases (von Willebrand's Disease) 01/2022 - 01/2021
1	Metrorrhagia (Spotting) 09/2021
1	Type 3 von Willebrand Disease 01/2021
1	Thrombophilia 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Hemarthrosis 01/2021
1	Wounds and Injuries (Trauma) 10/2020
1	Mucormycosis 10/2018
1	Thrombosis (Thrombus) 03/2017
1	Neutropenia 08/2015

Drug/Important Bio-Agent (IBA)

6	emicizumabIBA 09/2021 - 11/2019
2	Thrombin FDA Link 01/2022 - 03/2021
2	Factor VIII (Coagulation Factor VIII)IBA 08/2021 - 01/2021
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	marstacimabIBA 01/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Vitamin K FDA Link 01/2022
1	A-factor (Streptomyces)IBA 09/2021
1	Protein CIBA 01/2021
1	Factor X (Stuart Factor)IBA 11/2019
1	Factor IXa (Coagulation Factor IXa)IBA 11/2019
1	isavuconazoleIBA 10/2018
1	Rituximab (Mabthera)FDA Link 03/2017
1	AntibodiesIBA 03/2017
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2017
1	AutoantibodiesIBA 03/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2015

Therapy/Procedure

4	Therapeutics 01/2022 - 11/2019
1	Minor Surgical Procedures (Minor Surgery) 11/2019
1	Immunomodulation 03/2017